K2bio is a contract research organization that assists early-stage life science companies in advancing innovative therapies.
K2bio has raised $616K in total funding. The most recent round was Seed. The last funding was announced in August 2023.
K2bio is headquartered in Houston, United States.
K2bio is a contract research organization that assists early-stage life science companies in advancing innovative therapies.
K2bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"K2bio — Funding & Investors." VCBacked, August 1, 2023, https://www.vcbacked.co/company/k2bio. Accessed August 14, 2026.
VCBacked. (2023). K2bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/k2bio
{{cite web |title=K2bio — Funding & Investors |url=https://www.vcbacked.co/company/k2bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated